Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Porter

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Visualized Experiments : Jove|November 30, 2010
Crystallizing membrane proteins for structure determination using lipidic mesophasesMartin Caffrey, Christopher Porter
Urology Journal|July 13, 2014
The Whitaker testRichard B Johnston, Christopher Porter
Urology Practice|May 5, 2023
Anti-Tobacco Advertising-Is Bladder Cancer Adequately Addressed?Basil Ferenczi, Wai Lee, Jason Frankel, et al.
Oncology (Williston Park, N.Y.)|January 28, 2022
Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017Natasza Posielski, Hannah Koenig, On Ho, et al.
The Canadian Journal of Urology|October 13, 2020
Impact of catheter size on pain and continence following robotic prostatectomyAndrew Stamm, Basil Ferenczi, Christopher Porter, et al.
Urologic Oncology|May 26, 2022
Patient reported outcomes and health related quality of life in localized prostate cancer: A review of current evidenceEyal Kord, John Paul Flores, Natasza Posielski, et al.
Journal of Colloid and Interface Science|July 9, 2018
Deposition of sticky spheres in channel flow: Modeling of surface coverage evolution requires accurate sphere-sphere collision hydrodynamicsYoung Ki Lee, Christopher Porter, Scott L Diamond, et al.
Urologic Oncology|April 21, 2020
Combined chemotherapy and radiotherapy improves survival in 1897 testicular Lymphoma patients from a contemporary cohortFernando Caumont, Christopher Porter, Hannah DeBerg, et al.
The Oncologist|June 7, 2013
Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancerJacqueline Vuky, John M Corman, Christopher Porter, et al.
Cancer|January 9, 2009
Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancerJacqueline Vuky, Christopher Porter, Christina Isacson, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Visualized Experiments : Jove|November 30, 2010
Crystallizing membrane proteins for structure determination using lipidic mesophasesMartin Caffrey, Christopher Porter
Urology Journal|July 13, 2014
The Whitaker testRichard B Johnston, Christopher Porter
Urology Practice|May 5, 2023
Anti-Tobacco Advertising-Is Bladder Cancer Adequately Addressed?Basil Ferenczi, Wai Lee, Jason Frankel, et al.
Oncology (Williston Park, N.Y.)|January 28, 2022
Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017Natasza Posielski, Hannah Koenig, On Ho, et al.
The Canadian Journal of Urology|October 13, 2020
Impact of catheter size on pain and continence following robotic prostatectomyAndrew Stamm, Basil Ferenczi, Christopher Porter, et al.
Urologic Oncology|May 26, 2022
Patient reported outcomes and health related quality of life in localized prostate cancer: A review of current evidenceEyal Kord, John Paul Flores, Natasza Posielski, et al.
Journal of Colloid and Interface Science|July 9, 2018
Deposition of sticky spheres in channel flow: Modeling of surface coverage evolution requires accurate sphere-sphere collision hydrodynamicsYoung Ki Lee, Christopher Porter, Scott L Diamond, et al.
Urologic Oncology|April 21, 2020
Combined chemotherapy and radiotherapy improves survival in 1897 testicular Lymphoma patients from a contemporary cohortFernando Caumont, Christopher Porter, Hannah DeBerg, et al.
The Oncologist|June 7, 2013
Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancerJacqueline Vuky, John M Corman, Christopher Porter, et al.
Cancer|January 9, 2009
Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancerJacqueline Vuky, Christopher Porter, Christina Isacson, et al.
Pageof 4